Navigation Links
New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
Date:3/28/2010

Bayer Materials Science, LLC announces that its Sheffield Plastics business headquartered here has gained approval for its Makrolon® MAK 15 polycarbonate sheet as a high impact, break-resistant clear glazing material from the New York State Office of Mental Health.

Sheffield, MA (Vocus) March 28, 2010 -- Bayer Materials Science, LLC announces that its Sheffield Plastics business headquartered here has gained approval for its Makrolon® MAK 15 polycarbonate sheet as a high impact, break-resistant clear glazing material from the New York State Office of Mental Health.

The state agency approved the new product for exterior and interior applications after the material met rigorous performance standards for human impact, flammability and weathering life. These standards often serve as a benchmark for public facilities in other states as well.

According to the manufacturer, Makrolon MAK 15 is the result of a five-year R&D program with its parent-company Bayer Material Science, LLC. In addition to its inherent break-resistance, the new material delivers up to twice the abrasion resistance and weathering life due to UV exposure over prior polycarbonate sheet materials. As a result, provides longer life and reduced maintenance for external glazing and for interior partitions, windows and doors.

Based on performance improvements made possible with its new technology, Sheffield Plastics also backs Makrolon MAK 15 with an unprecedented 15 year warranty on weathering life, yellowing, abrasion resistance and breakage.

The new product is available through the manufacturer’s national network of distributors. Administrators and facilities managers can find complete information on the product at www.sheffieldplastics.com or by calling the company at 1-877- 413-7957.

Bayer MaterialScience LLC is one of the leading producers of polymers and high-performance plastics in North America and is part of the global Bayer MaterialScience business with nearly 15,100 employees at 30 sites around the world and 2008 sales of 9.7 billion euros. Business activities are focused on the manufacture of high-tech polymer materials and the development of innovative solutions for products used in many areas of daily life. The main segments served are the automotive, electrical and electronics, construction, medical, and sports and leisure industries.

Contact:
Cindy Kahlstrom
Phone: 413-528-7812
E-mail: cindy(dot)kahlstrom(at)bayerbms(dot)com

For more information about Bayer MaterialScience, call 1-800-628-5084, email us at info(at)sheffieldplastics(dot)com or visit www.sheffieldplastics.com

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our annual and interim reports filed with the Frankfurt Stock Exchange. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

# # #

Read the full story at http://www.prweb.com/releases/2010/03/prweb3790624.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Carefx Portal Solution to Deliver First Time, Statewide Access to Patient Data Among Hospitals in the LSU Network
2. MHPA Statement on Health Reform Legislation
3. Prostate Cancer Treatment Database Hits Milestone of 12,500
4. BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now
5. Statement of Ralph B. Everett, President and CEO, Joint Center for Political and Economic Studies, on House Passage of Health Reform Legislation
6. Pew Applauds Federal Grant Program Supporting State Expansion of Evidence-Based Home Visitation
7. Male Infertility Significantly Increases Risk of Prostate Cancer
8. Texas is 39th State to Defend Health Care Choice
9. Statement of US Secretary of Labor Hilda L. Solis on passage of health care reform by US House of Representatives
10. GlaxoSmithKline Statement on New Information Relating to Manufacture of Rotarix (Rotavirus Vaccine)
11. Infertility Raises Risk of More Aggressive Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New York State Office of Mental Health Approves New High Performance Polycarbonate Sheet for Use in All Facilities
(Date:3/23/2017)... ... March 23, 2017 , ... ... families and businesses of the Norwalk and Vermillion areas, celebrates the newest ... (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer recovery support ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits delivery trailblazer, Hodges-Mace, ... and centralized benefits dashboard solving one of the top frustrations in employee benefits ... the first time, employees can access up-to-date information and account balances for all ...
(Date:3/23/2017)... ... March 23, 2017 , ... Hakim Unique Group ... technology company California Healthcom Group (CHG). , The HUG investment is a ... headquarters in California, CHG is a growing, internationally recognized healthcare management, technology, and ...
(Date:3/23/2017)... Scottsdale, AZ (PRWEB) , ... March 23, 2017 , ... ... helping people around the world to manage stress and anxiety. , “Buzzies change ... Serin, neuropsychologist, inventor and co-founder of Buzzies. , Since its launch date in December ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... a new solution that enables organizations to easily reprint customer invoices, bills, statements ... Server’ automates all of the steps needed to retrieve and print the documents ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017   Icertis , the leading ... the cloud, today announced an upgrade to the ... to improve clinical trials contract management. Built on ... the solution speeds up clinical trial contracting while ... (CRO). "The pharmaceutical industry is ...
(Date:3/23/2017)... March 23, 2017 A research report ... is expected to reach USD 7.2 billion by the end ... preparation is a procedure in which a sample is preserved ... most analytical procedures since the methods are often allowing repeated ... of the most shared procedures in the lab. In many ...
(Date:3/23/2017)... , March 23, 2017 Ascendis Pharma A/S ... TransCon technology to address significant unmet medical needs in ... a conference call and webcast on Monday, April 3 ... Society in Orlando, Florida , to ... candidates (TransCon Growth Hormone, TransCon PTH and TransCon CNP). ...
Breaking Medicine Technology: